The Effect of Craniosacral Therapy as Additive Procedure. | Clinical Trial | StuddyBuddy@endsection
← Back to all trials
Completed
NCT05722756
The Effect of Craniosacral Therapy as Additive Procedure.
Conditions: Central Nervous System Diseases
Sex: All
Ages: 1 Month – 6 Months
Enrollment: 51
Sponsor: Wroclaw Medical University
Summary
This observational, retrospective study has shown, that the addition of craniosacral therapy to the Vojta method has improved the effects of the therapy in 6 months follow-up period.
The chance for improvement was 9.42 times higher in Vojta + craniosacral group compared to the group conducted only with Vojta method.The study results suggest that the craniosacral procedure should be considered as an additive regimen to the Vojta method in the therapy of children with central coordination disorders (CCD) .
More data is still needed to improve the rehabilitation process in this group of patients.
Eligibility Criteria
Inclusion criteria:CCD (central coordination disorders) diagnosis based on the paediatrician's opinion with a decision that the child needs rehabilitation;a score of 8- 10 on the APGAR scale in the first minute of life;no major birth defects documented that can push the diagnosis into the diagnosis of genetic disorders;the age of the child at the time of the assessment of its eligibility for rehabilitation: 1-6 months (of life), calculated based on completed months of life;available information regarding an abnormal result of the Vojta test, defined as at least 6 abnormal reactions (marked as abnormal [AN], or delayed [OP] in the test report) with abnormal muscle tension, which indicates moderate to severe CCD;available information regarding the first medical examination (during the first visit (W0)), and a follow-up visit after 6 months (W6) on the determined date, maintaining the defined timeframe (5.5-6 months after W0).Exclusion criteria (medical history was excluded from the analysis even if one of the following exclusion criteria was met):children who obtained a score of < 8 points on the APGAR scale in the first minute of life;suspicion of any major (significant) birth defect, congenital defect syndrome (e.g.
Down syndrome, Sotos syndrome) and/or indications for consultation at Genetics Clinic based on paediatric records;age < 1 month or > 6 months;< 6 abnormal reactions during the Vojta test at the first eligibility visit, which indicates mild or very mild CCD.
Source: ClinicalTrials.gov (NCT05722756). StuddyBuddy aggregates publicly available trial information.